SS

Sangita Sahebrao Dasgude

Active Director Director DIN 10819816
DIN 10819816 First appointment Oct 2024 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangita Sahebrao Dasgude

Data last updated:

Sangita Sahebrao Dasgude is a Director at Achemvia Biosciences Private Limited (since 2024). The company operates in Chemicals.

DIN 10819816
Primary Designation Director
Industry Chemicals
First Appointment 29 Oct 2024
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Achemvia Biosciences Private Limited U24119PN2011PTC138280
Director29 Oct 20242011Active

Board colleagues of Sangita Sahebrao Dasgude

NameDINCompanyDesignation
Sumit Sahebrao Dasgude10822432Achemvia Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Achemvia Biosciences Private Limited
Premium access

Shareholding and investment profile for Sangita Sahebrao Dasgude

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangita Sahebrao Dasgude

Sangita Sahebrao Dasgude currently holds 1 directorship: Achemvia Biosciences Private Limited (Director, since 29 Oct 2024).

Sangita Sahebrao Dasgude was first appointed on 29 Oct 2024 as Director at Achemvia Biosciences Private Limited.

The current boards of Sangita Sahebrao Dasgude's companies include Sumit Sahebrao Dasgude (Achemvia Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available